Showing results (161-170 of 199) with videos related to
Sort By:
Pageof 20
Osterreichische Zeitschrift Fur Onkologie. Austrian Journal of Oncology|January 1, 1975
[Phospholipids under combined ozone-oxygen administration]E Müller-Tyl, P Hernuss, H Salzer, et al.Pediatric Research|December 1, 1986
Studies on the effects of L-thyroxine, L-carnitine and an L-thyroxine-L-carnitine combination on dipalmitoyl phosphatidylcholine content and on phosphatidylcholine species composition in fetal rat lungsA Lohninger, H P Krieglsteiner, H Salzer, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 14, 2015
Interobserver agreement and accuracy of non-invasive diagnosis of endometriosis by transvaginal sonographyA Tammaa, N Fritzer, P Lozano, et al.Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1986
Studies on the effects of betamethasone, L-carnitine, and betamethasone-L-carnitine combinations on the dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in foetal rat lungsA Lohninger, H P Krieglsteiner, H Salzer, et al.International Journal of Cancer|January 15, 1994
Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometryT M Wagner, A Adler, P Sevelda, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2013
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practiceK Krzemieniecki, P Sevelda, F Erdkamp, et al.Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.Geburtshilfe Und Frauenheilkunde|June 1, 1992
[Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status]P Speiser, G Sliutz, R Zeillinger, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Long-term influence of adjuvant therapy on natural killer cell activity in breast cancerE Tichatschek, C C Zielinski, C Müller, et al.Pageof 20